A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,960

Participants

Timeline

Start Date

April 14, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

February 28, 2029

Conditions
Peripheral Vascular DiseasesKidney Diseases
Interventions
DRUG

CO2

CO2 will be used as contrast medium sparing strategy during peripheral angiography

DRUG

Iodinated Contrast Media (ICM)

Iodinated contrast medium will be used as in routine care during peripheral angiography

Trial Locations (9)

Unknown

NOT_YET_RECRUITING

Tirol Kliniken Innsbruck, Innsbruck

RECRUITING

Universitätsklinik für Innere Medizin II, Vienna

NOT_YET_RECRUITING

Kreiskrankenhaus Alsfeld, Alsfeld

NOT_YET_RECRUITING

Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen

NOT_YET_RECRUITING

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt a.M.

NOT_YET_RECRUITING

Universitätsklinikum Leipzig, Leipzig

NOT_YET_RECRUITING

Klinikum rechts der Isar der Technischen Universität München, München

NOT_YET_RECRUITING

MEDINOS Kliniken des Landkreises Sonneberg GmbH, Sonneberg

NOT_YET_RECRUITING

GRN - Klinik Weinheim, Weinheim

All Listed Sponsors
lead

University of Leipzig

OTHER